Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Context Capital Management | 53M | $35B | 129596% | Dec 2023 |
|
Wolverine Asset Management | 45M | $30M | 0% | Dec 2023 |
|
D. E. Shaw & Co | 41M | $27M | 0% | Dec 2023 |
|
Highbridge Capital Management | 29M | $19B | 10% | Dec 2023 |
|
Lazard Asset Management | 25M | $17M | 4% | Dec 2023 |
|
Citigroup | 20M | $13M | 0% | Dec 2023 |
|
Aviva | 20M | $13M | -13% | Dec 2023 |
|
Capstone Investment Advisors | 19M | $13M | -17% | Dec 2023 |
|
Braidwell | 17M | $11M | -41% | Dec 2023 |
|
Segantii Capital Management | 10M | $6.7M | 33% | Dec 2023 |
|
Jane Street | 3.6M | $2.4M | 33% | Dec 2023 |
|
Readystate Asset Management | 3.0M | $2.0M | 0% | Dec 2023 |
|
Point72 Asset Management | 2.6M | $1.7M | 0% | Dec 2023 |
|
Lion Point Capital | 1.0M | $671k | 0% | Dec 2023 |
|
Nomura Holdings | 482k | $4.3M | 1% | Dec 2023 |
|
Jpmorgan Chase & Co | 125k | $81k | 0% | Dec 2023 |
|
Who sold out of Travere Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Caas Capital Management | Sep 2023 | 500k | $317k |